122 related articles for article (PubMed ID: 11576933)
1. Localization of imidazolone in the peritoneum of capd patients: a factor for a loss of ultrafiltration.
Nakamura S; Miyazaki S; Sakai S; Morita T; Hirasawa Y; Niwa T
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S107-10. PubMed ID: 11576933
[TBL] [Abstract][Full Text] [Related]
2. Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients.
Nakamura S; Tachikawa T; Tobita K; Miyazaki S; Sakai S; Morita T; Hirasawa Y; Weigle B; Pischetsrieder M; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S61-7. PubMed ID: 12612955
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end-products and peritoneal sclerosis.
Nakamura S; Niwa T
Semin Nephrol; 2004 Sep; 24(5):502-5. PubMed ID: 15490420
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of an AGE, a ligand for macrophage receptor, in peritoneum of CAPD patients.
Nakamura S; Tobita K; Tachikawa T; Akamatsu S; Ohno Y; Kan A; Katsuragawa M; Yasumura K; Miyazaki S; Sakai S; Morita T; Hirashawa Y; Niwa T
Kidney Int Suppl; 2003 May; (84):S152-7. PubMed ID: 12694334
[TBL] [Abstract][Full Text] [Related]
5. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD.
Nakayama M; Kawaguchi Y; Yamada K; Hasegawa T; Takazoe K; Katoh N; Hayakawa H; Osaka N; Yamamoto H; Ogawa A; Kubo H; Shigematsu T; Sakai O; Horiuchi S
Kidney Int; 1997 Jan; 51(1):182-6. PubMed ID: 8995732
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.
Honda K; Nitta K; Horita S; Yumura W; Nihei H; Nagai R; Ikeda K; Horiuchi S
Nephrol Dial Transplant; 1999 Jun; 14(6):1541-9. PubMed ID: 10383022
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitis.
Selgas R; Muñoz J; Cigarran S; Ramos P; L-Revuelta K; Escuin F; Miguel JL
Perit Dial Int; 1989; 9(4):329-32. PubMed ID: 2577360
[TBL] [Abstract][Full Text] [Related]
9. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis.
Shioshita K; Miyazaki M; Ozono Y; Abe K; Taura K; Harada T; Koji T; Taguchi T; Kohno S
Kidney Int; 2000 Feb; 57(2):619-31. PubMed ID: 10652040
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.
Davies SJ; Bryan J; Phillips L; Russell GI
Nephrol Dial Transplant; 1996 Mar; 11(3):498-506. PubMed ID: 8671821
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes.
Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT
Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887
[TBL] [Abstract][Full Text] [Related]
12. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.
Slingeneyer A; Canaud B; Mion C
Nephron; 1983; 33(2):133-8. PubMed ID: 6835460
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure.
de Alvaro F; Castro MJ; Dapena F; Bajo MA; Fernandez-Reyes MJ; Romero JR; Jimenez C; Miranda B; Selgas R
Adv Perit Dial; 1993; 9():56-61. PubMed ID: 8105963
[TBL] [Abstract][Full Text] [Related]
14. Morphological studies of mesothelial cells in CAPD effluent and their clinical significance.
Yamamoto T; Izumotani T; Otoshi T; Kim M
Am J Kidney Dis; 1998 Dec; 32(6):946-52. PubMed ID: 9856509
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal verapamil therapy in CAPD patients with peritoneal hypopermeability. Effects on ultrafiltration.
Lamperi S; Carozzi S; Nasini MG; Canepa M; Zanin T
ASAIO Trans; 1988; 34(3):425-8. PubMed ID: 3196541
[TBL] [Abstract][Full Text] [Related]
16. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
17. Peritonitis increases MMP-9 activity in peritoneal effluent from CAPD patients.
Fukudome K; Fujimoto S; Sato Y; Hisanaga S; Eto T
Nephron; 2001 Jan; 87(1):35-41. PubMed ID: 11174024
[TBL] [Abstract][Full Text] [Related]
18. Relationship between malnutrition-inflammation syndrome and ultrafiltration volume in continuous ambulatory peritoneal dialysis patients.
Tinroongroj N; Jittikanont S; Lumlertgul D
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S94-100. PubMed ID: 22043574
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis.
Rodrigues A; Cabrita A; Maia P; Guimarães S
Adv Perit Dial; 2002; 18():78-80. PubMed ID: 12402593
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal clearances, protein losses and ultrafiltration in diabetic patients after four years on CAPD.
Coronel F; Tornero F; Macia M; Sánchez A; De Oleo P; Naranjo P; Barrientos A
Adv Perit Dial; 1991; 7():35-8. PubMed ID: 1680453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]